Cargando…
Straight talk with...Donna Ambrosino
In the 1890s, a diphtheria epidemic was killing thousands of children across the US, prompting many state health departments to create laboratories to start extracting antiserum from horses' blood. More than a century later, however, only one of these public labs is still in operation: the Mass...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096041/ https://www.ncbi.nlm.nih.gov/pubmed/21383712 http://dx.doi.org/10.1038/nm0311-240 |
_version_ | 1783510739785351168 |
---|---|
author | Dolgin, Elie |
author_facet | Dolgin, Elie |
author_sort | Dolgin, Elie |
collection | PubMed |
description | In the 1890s, a diphtheria epidemic was killing thousands of children across the US, prompting many state health departments to create laboratories to start extracting antiserum from horses' blood. More than a century later, however, only one of these public labs is still in operation: the Massachusetts Biologic Laboratories, known simply as MassBiologics. Established in 1894 as the Massachusetts Public Health Laboratories, it is now the only nonprofit, licensed vaccine and biologics manufacturer and research center in the country—which gives the lab a unique position to tackle diseases that 'big pharma' isn't willing to touch. Leading the charge is Executive Director Donna Ambrosino, who took the helm in 1998 after a 20-year career at the Dana Farber Cancer Institute in Boston. On a snowy day in January, Elie Dolgin sat down to chat with Ambrosino at MassBiologics's brand new research center, opened last summer in the outskirts of Boston. |
format | Online Article Text |
id | pubmed-7096041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70960412020-03-26 Straight talk with...Donna Ambrosino Dolgin, Elie Nat Med Article In the 1890s, a diphtheria epidemic was killing thousands of children across the US, prompting many state health departments to create laboratories to start extracting antiserum from horses' blood. More than a century later, however, only one of these public labs is still in operation: the Massachusetts Biologic Laboratories, known simply as MassBiologics. Established in 1894 as the Massachusetts Public Health Laboratories, it is now the only nonprofit, licensed vaccine and biologics manufacturer and research center in the country—which gives the lab a unique position to tackle diseases that 'big pharma' isn't willing to touch. Leading the charge is Executive Director Donna Ambrosino, who took the helm in 1998 after a 20-year career at the Dana Farber Cancer Institute in Boston. On a snowy day in January, Elie Dolgin sat down to chat with Ambrosino at MassBiologics's brand new research center, opened last summer in the outskirts of Boston. Nature Publishing Group US 2011-03-07 2011 /pmc/articles/PMC7096041/ /pubmed/21383712 http://dx.doi.org/10.1038/nm0311-240 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2011 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Dolgin, Elie Straight talk with...Donna Ambrosino |
title | Straight talk with...Donna Ambrosino |
title_full | Straight talk with...Donna Ambrosino |
title_fullStr | Straight talk with...Donna Ambrosino |
title_full_unstemmed | Straight talk with...Donna Ambrosino |
title_short | Straight talk with...Donna Ambrosino |
title_sort | straight talk with...donna ambrosino |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096041/ https://www.ncbi.nlm.nih.gov/pubmed/21383712 http://dx.doi.org/10.1038/nm0311-240 |
work_keys_str_mv | AT dolginelie straighttalkwithdonnaambrosino |